Selective cell-cycle arrest and induction of apoptosis in proliferating neural cells by ganglioside GM3

Y Nakatsuji1, R H Miller

  • 1Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.

Experimental Neurology
|March 22, 2001
PubMed

Insights

The simple ganglioside GM3 inhibits neural progenitor proliferation and induces apoptosis in the developing central nervous system (CNS). This finding suggests GM3

Area of Science:

  • Neuroscience
  • Cell Biology
  • Developmental Biology

Background:

  • Cell proliferation and survival are crucial for vertebrate central nervous system (CNS) development.
  • Early CNS development involves significant apoptosis, but its inducers are not fully understood.
  • Gangliosides, including GM3, are sialylated glycosphingolipids found in the CNS, potentially regulating cell growth.

Purpose of the Study:

  • To investigate the role of the simple ganglioside GM3 in regulating cell proliferation and apoptosis in the developing CNS.
  • To determine if GM3 affects neural progenitor cells, such as astrocyte precursors.

Main Methods:

  • Administered GM3 intraventricularly to neonatal rodents.
  • Assessed the effects of GM3 on cell proliferation and apoptosis in the CNS ventricular and subventricular zones.
  • Investigated the involvement of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) in GM3-mediated inhibition of astrocyte precursor proliferation.

Main Results:

  • GM3 selectively inhibited proliferation and induced apoptosis in actively dividing astrocyte precursors and other neural progenitors.
  • Intraventricular GM3 administration significantly reduced proliferation and increased apoptosis in the neonatal CNS ventricular and subventricular zones.
  • GM3-induced inhibition of astrocyte precursor proliferation was partly mediated by the Cdk inhibitor p27(Kip1).

Conclusions:

  • The simple ganglioside GM3 plays a regulatory role in controlling cell proliferation and death within the developing CNS.
  • GM3's ability to inhibit neural progenitor proliferation and induce apoptosis suggests potential therapeutic applications for brain tumors.

Related Concept Videos